ORIC® Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Rhea-AI Summary

ORIC Pharmaceuticals (Nasdaq: ORIC) said management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Wednesday, December 3, 2025 at 11:15 a.m. ET and will hold one-on-one investor meetings.

The live webcast will be available via the company’s investor website and a replay will be accessible for 90 days after the event.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating in a fireside chat at the 8^th Annual Evercore Healthcare Conference on Wednesday, December 3, 2025, at 11:15 a.m. ET. Management will also be participating in one-on-one meetings.

The webcast of the fireside chat discussion will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.

About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) enozertinib (ORIC-114), a brain-penetrant inhibitor that selectively targets EGFR exon 20, EGFR atypical, and HER2 exon 20 mutations, being developed across multiple genetically defined cancers. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.

Contact:

Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com
info@oricpharma.com

FAQ

When will ORIC (ORIC) present at the Evercore Healthcare Conference in 2025?

ORIC will present on Wednesday, December 3, 2025 at 11:15 a.m. ET.

How can investors watch ORIC's (ORIC) fireside chat webcast?

The webcast will be available through ORIC's investor website at www.oricpharma.com.

Will ORIC (ORIC) make a replay of the Evercore presentation available?

Yes. A replay of the webcast will be available for 90 days following the event.

Is ORIC (ORIC) holding one-on-one investor meetings at the Evercore conference?

Yes. Management will be participating in one-on-one meetings in addition to the fireside chat.

What topics will ORIC (ORIC) management discuss at the December 3, 2025 fireside chat?

Management will discuss the company’s clinical-stage programs and strategy; the announcement lists a fireside chat and meetings but does not provide a detailed agenda.

Where can I find the webcast link and replay for ORIC's (ORIC) Evercore presentation?

The live webcast and replay link will be posted in the Investor section of ORIC's website at www.oricpharma.com.